PortfoliosLab logoPortfoliosLab logo
IESC vs. SMMT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IESC vs. SMMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IES Holdings, Inc. (IESC) and Summit Therapeutics Inc. (SMMT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IESC achieves a 88.91% return, which is significantly higher than SMMT's -19.33% return. Over the past 10 years, IESC has outperformed SMMT with an annualized return of 48.95%, while SMMT has yielded a comparatively lower 4.15% annualized return.


IESC

1D
1.97%
1M
10.23%
YTD
88.91%
6M
66.06%
1Y
162.49%
3Y*
140.27%
5Y*
69.06%
10Y*
48.95%

SMMT

1D
-4.47%
1M
-21.96%
YTD
-19.33%
6M
-24.24%
1Y
-31.47%
3Y*
100.52%
5Y*
13.84%
10Y*
4.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IESC vs. SMMT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IESC
IES Holdings, Inc.
88.91%93.58%153.67%122.72%-29.76%9.99%79.42%65.02%-9.86%-9.92%
SMMT
Summit Therapeutics Inc.
-19.33%-1.99%583.72%-38.59%57.99%-42.77%193.75%39.13%-89.62%29.44%

Correlation

The correlation between IESC and SMMT is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Mar 5, 2015

0.13

Fundamentals

Market Cap

IESC:

$14.83B

SMMT:

$10.94B

EPS

IESC:

$18.85

SMMT:

-$1.60

PB Ratio

IESC:

13.83

SMMT:

20.04

Total Revenue (TTM)

IESC:

$3.63B

SMMT:

$0.00

Gross Profit (TTM)

IESC:

$931.31M

SMMT:

-$83.36K

EBITDA (TTM)

IESC:

$487.14M

SMMT:

-$738.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IESC vs. SMMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IESC
IESC Risk / Return Rank: 9292
Overall Rank
IESC Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
IESC Sortino Ratio Rank: 8888
Sortino Ratio Rank
IESC Omega Ratio Rank: 8888
Omega Ratio Rank
IESC Calmar Ratio Rank: 9696
Calmar Ratio Rank
IESC Martin Ratio Rank: 9696
Martin Ratio Rank

SMMT
SMMT Risk / Return Rank: 2525
Overall Rank
SMMT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
SMMT Sortino Ratio Rank: 2828
Sortino Ratio Rank
SMMT Omega Ratio Rank: 2828
Omega Ratio Rank
SMMT Calmar Ratio Rank: 2121
Calmar Ratio Rank
SMMT Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IESC vs. SMMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IES Holdings, Inc. (IESC) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IESCSMMTDifference
Sharpe ratioReturn per unit of total volatility

+3.06

Sortino ratioReturn per unit of downside risk

+2.98

Omega ratioGain probability vs. loss probability

1.39

0.98

+0.40

Calmar ratioReturn relative to maximum drawdown

7.50

-0.60

+8.10

Martin ratioReturn relative to average drawdown

21.33

-0.92

+22.25

IESC vs. SMMT - Sharpe Ratio Comparison

The current IESC Sharpe Ratio is 2.64, which is higher than the SMMT Sharpe Ratio of -0.42. The chart below compares the historical Sharpe Ratios of IESC and SMMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IESCSMMTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.64

-0.42

+3.06

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.29

0.08

+1.21

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.02

0.03

+0.99

Sharpe Ratio (All Time)

Calculated using the full available price history

0.05

0.02

+0.03

Drawdowns

IESC vs. SMMT - Drawdown Comparison

The maximum IESC drawdown since its inception was -98.32%, roughly equal to the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for IESC and SMMT.


Loading charts...

Drawdown Indicators


IESCSMMTDifference

Max Drawdown

Largest peak-to-trough decline

-98.32%

-95.75%

-2.57%

Max Drawdown (1Y)

Largest decline over 1 year

-21.80%

-52.76%

+30.96%

Max Drawdown (3Y)

Largest decline over 3 years

-49.23%

-62.26%

+13.03%

Max Drawdown (5Y)

Largest decline over 5 years

-54.22%

-91.78%

+37.56%

Max Drawdown (10Y)

Largest decline over 10 years

-54.28%

-95.75%

+41.47%

Current Drawdown

Current decline from peak

-0.97%

-61.55%

+60.58%

Average Drawdown

Average peak-to-trough decline

-55.01%

-57.64%

+2.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.66%

34.32%

-26.66%

Volatility

IESC vs. SMMT - Volatility Comparison

The current volatility for IES Holdings, Inc. (IESC) is 11.77%, while Summit Therapeutics Inc. (SMMT) has a volatility of 22.47%. This indicates that IESC experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IESCSMMTDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.77%

22.47%

-10.70%

Volatility (6M)

Calculated over the trailing 6-month period

49.79%

56.53%

-6.74%

Volatility (1Y)

Calculated over the trailing 1-year period

62.06%

75.95%

-13.89%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.94%

185.12%

-131.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.10%

144.63%

-96.53%

Dividends

IESC vs. SMMT - Dividend Comparison

Neither IESC nor SMMT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

IESC vs. SMMT - Financials Comparison

This section allows you to compare key financial metrics between IES Holdings, Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B20222023202420252026
974.20M
0
(IESC) Total Revenue
(SMMT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


IESC and SMMT have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMMT has higher volatility (22.47%) compared to IESC (11.77%). In terms of maximum drawdown, IESC dropped -98.32% vs SMMT's -95.75%.

IESC currently has the higher Sharpe Ratio (2.64 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IESC and SMMT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer